PMC:7212965 / 4151-4423 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":247,"end":256},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma9639"}],"text":"2%) received invasive mechanical ventilation, in whom the mortality rate was 88.1% (282 of 320)].5\nAngiotensin converting enzyme II, believed to be the target entry receptor for SARS-CoV-2, is abundantly expressed in gastric, duodenal, and rectal epithelia, thereby implic"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T9","span":{"begin":247,"end":256},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0000483"}],"text":"2%) received invasive mechanical ventilation, in whom the mortality rate was 88.1% (282 of 320)].5\nAngiotensin converting enzyme II, believed to be the target entry receptor for SARS-CoV-2, is abundantly expressed in gastric, duodenal, and rectal epithelia, thereby implic"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T31","span":{"begin":178,"end":186},"obj":"Disease"}],"attributes":[{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"2%) received invasive mechanical ventilation, in whom the mortality rate was 88.1% (282 of 320)].5\nAngiotensin converting enzyme II, believed to be the target entry receptor for SARS-CoV-2, is abundantly expressed in gastric, duodenal, and rectal epithelia, thereby implic"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11","span":{"begin":99,"end":110},"obj":"Chemical"},{"id":"T12","span":{"begin":129,"end":131},"obj":"Chemical"}],"attributes":[{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_2719"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"2%) received invasive mechanical ventilation, in whom the mortality rate was 88.1% (282 of 320)].5\nAngiotensin converting enzyme II, believed to be the target entry receptor for SARS-CoV-2, is abundantly expressed in gastric, duodenal, and rectal epithelia, thereby implic"}

{"project":"LitCovid-PubTator","denotations":[{"id":"141","span":{"begin":58,"end":67},"obj":"Disease"},{"id":"144","span":{"begin":178,"end":188},"obj":"Species"}],"attributes":[{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"MESH:D003643"},{"id":"A144","pred":"tao:has_database_id","subj":"144","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"2%) received invasive mechanical ventilation, in whom the mortality rate was 88.1% (282 of 320)].5\nAngiotensin converting enzyme II, believed to be the target entry receptor for SARS-CoV-2, is abundantly expressed in gastric, duodenal, and rectal epithelia, thereby implic"}